Posted inConferences News Research Treatment HIV viral rebounds following CRISPR gene therapy Posted by By Tom Hayes-Isaacs 2024-08-06 EBT-101, a gene-editing therapy utilising CRISPR technology, showed promising safety and tolerability in an initial…
Posted inHealthcare Medicines News Parenting PrEP Prevention Research Cabotegravir PrEP injection is safe during pregnancy Posted by By Tom Hayes-Isaacs 2024-07-30 The safety and tolerability of long-acting injectable cabotegravir (CAB-LA) as HIV pre-exposure prophylaxis (PrEP) for…
Posted inConferences Healthcare Medicines News PrEP Prevention Twice-yearly lenacapavir injection sees zero HIV infections in trial Posted by By Tom Hayes-Isaacs 2024-07-25 AIDS 2024 Conference Coverage Preliminary findings from the phase III PURPOSE 1 trial revealed that…
Posted inConferences Events News IAS AIDS 2024 starts in Munich Posted by By Tom Hayes-Isaacs 2024-07-23 AIDS 2024, the 25th International AIDS Conference hosted by the International AIDS Society, kicked off…